Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Pituitary Neoplasms × Thyrotropin-Releasing Hormone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Diseases 1 Pituitary Neoplasms 1 Pituitary Diseases 1 Hypothyroidism 1 Cancer-related Fatigue 1

Interventions

pasireotide 3 lutetium Lu 177 dotatate 1 farletuzumab 1 Thyrotropin-Releasing Hormone 1 Temozolomide 1 TBR-760 1 Rosiglitazone 1 Nivolumab 1 Microarray Analysis 1 Ipilimumab 1 DNA Methylation 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00054756 2018-08-08

Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

96 enrolled 6 charts

EndocrineHead & Neck

Hypothyroidism, Pituitary Diseases, Pituitary Neoplasms, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡